Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.24.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Mar. 31, 2023
Current assets:    
Cash and cash equivalents $ 2,406 $ 3,820
Accounts receivable, net 2,876 2,572
Inventories, net 2,955 2,858
Prepaid expenses and other current assets 4,009 4,308
Current portion of deferred consideration, net of discount 256 240
Total current assets 12,502 13,798
Property and equipment, net 397 488
Operating lease, right of use assets 341 418
Deferred tax asset 922 949
Deferred consideration, net of discount, less current portion 378 505
Other assets 78 73
Total assets 14,618 16,231
Current liabilities:    
Accounts payable 864 841
Accrued expenses and other current liabilities 1,847 2,029
Deferred revenue 75 100
Deferred revenue Invekra 63 60
Short-term debt 44 431
Operating lease liabilities 181 256
Total current liabilities 3,074 3,717
Long-term deferred revenue Invekra 101 140
Withholding tax payable 4,591 4,235
Operating lease liabilities, less current portion 160 162
Total liabilities 7,926 8,254
Commitments and Contingencies (Note 5)
Stockholders’ Equity    
Convertible preferred stock, $0.0001 par value; 714,286 shares authorized at December 31, 2023 and March 31, 2023, respectively, no shares issued and outstanding at December 31, 2023 and March 31, 2023, respectively 0 0
Common stock, $0.0001 par value; 24,000,000 shares authorized at December 31, 2023 and March 31, 2023, respectively, 13,684,333 and 4,933,550 shares issued and outstanding at December 31, 2023 and March 31, 2023, respectively (Note 7) 2 5
Additional paid-in capital 202,795 200,904
Accumulated deficit (193,282) (189,514)
Accumulated other comprehensive loss (2,823) (3,418)
Total stockholders’ equity 6,692 7,977
Total liabilities and stockholders’ equity $ 14,618 $ 16,231